This PDF file includes: Surface CCR9 expression in lymphocytes was measured using the peripheral blood mononuclear cells (PBMCs) harvested from 11 healthy female volunteers (HV) and 10 breast cancer patients (TNBC (A) 4T1 tumor-bearing mice were intravenously administrated with PBS, free Cy5-siCD47 + Cy3-CCL25, NP-Cy5-siCD47, NP-Cy5-siCD47/Cy3-CCL25. Brains, hearts, lungs, tumors, livers, spleens, kidneys and intestines were harvested at 24 h after the treatment. The fluorescent images were conducted using a Xenogen IVIS system. The CD47 siRNA and CCL25 were labeled with Cy5 and Cy3, respectively. The dose of Cy5-siRNA and Cy3-CCL25 were 4.7 mg/kg and 294 µg/kg, respectively. (B) Corresponding quantification of Cy5 (left) and Cy3 (tight) signals in brain, lung, heart, liver, spleen and kidney in (A). (C) CLSM images showed each color channel of the merged images in Fig. 2C . The CD47 siRNA and CCL25 were labeled with Cy5 (red) and Cy3 (yellow), respectively. The cell membrane and nuclei were stained with FITC-phalloidin (green) and DAPI (blue), respectively. The scale bar is 10 µm. antibody or PBS was given by i.p. injection every three days for 8 times starting from day 2 (n =
